Millennium Management’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
BBA
Millennium Management's PRAX Position: Q3 2026 in Review
Millennium Management increased its Praxis Precision Medicines (PRAX) stake by 638% in Q3 2026, buying an estimated $2.1M and bringing the position to 7,339 shares worth $2.14M. The position accounts for ﹤0.01% of the portfolio, ranked #3864.
Millennium Management first reported a position in PRAX in Q1 2021 and has held it in 20 quarters since. The position peaked at $11.6M in Q4 2024. 335 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.
- Millennium Management held 7,339 shares of Praxis Precision Medicines worth $2.14M as of Q3 2026.
- Millennium Management bought 6,344 Praxis Precision Medicines shares in Q3 2026, an estimated $2.1M.
- Praxis Precision Medicines made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #3864 holding.
- Millennium Management first reported a position in Praxis Precision Medicines in Q1 2021 and has held it in 20 quarters since.
- Millennium Management's Praxis Precision Medicines position peaked at $11.6M in Q4 2024.
- 335 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.
Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.